Subtyping of Insomnia Disorders Based on Multidimensional Features

Launched by SHANGHAI MENTAL HEALTH CENTER · Aug 3, 2023

Keywords

ClinConnect Summary

This clinical trial is studying different types of insomnia, which is a sleep disorder that makes it hard for people to fall asleep or stay asleep. The research aims to understand the various symptoms and characteristics of chronic insomnia by looking at factors like sleep patterns, brain activity, and genetic information. The goal is to create a personalized approach to treatment, helping doctors provide better care for those struggling with insomnia.

To take part in this study, participants need to be between 18 and 65 years old and currently diagnosed with insomnia. They should have a specific score on a sleep quality questionnaire that indicates their insomnia is significant. However, this study is not for those with other sleep disorders, certain medical conditions, or specific mental health issues. Participants will undergo various assessments, including tests to monitor their sleep, and will contribute to developing new treatment strategies for insomnia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Aged between 18 and 65 years, regardless of gender;
• • 2. Currently meeting the diagnostic criteria for insomnia disorder according to the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
• • 3. Pittsburgh Sleep Quality Index (PSQI) total score ≥ 10;
• • 4. Sufficient level of education and comprehension to complete the required examinations and assessments for this study;
• • 5. Voluntarily participating in this research and signing the informed consent form.
• Exclusion Criteria:
• • 1. Currently diagnosed with other sleep disorders (sleep-related breathing disorders, periodic limb movement disorder, parasomnias, central disorders of hypersomnolence, circadian rhythm sleep-wake disorders, etc.);
• • 2. Currently diagnosed with organic brain diseases (epilepsy, cerebrovascular disease, etc.) or other organic diseases;
• • 3. Patients with a history of or currently diagnosed with bipolar and related disorders, obsessive-compulsive and related disorders, schizophrenia spectrum and other psychotic disorders, trauma and stressor-related disorders, dissociative disorders, or eating disorders;
• • 4. Women who are pregnant, breastfeeding, or planning to become pregnant during the study period;
• • 5. Insomnia caused by alcohol or substance abuse;
• • 6. High suicide risk, with HAMD-17 suicide factor score \> 2;
• • 7. Inability to cooperate with near-infrared examinations and polysomnography due to physical conditions such as head injury, etc.